AA-1 | Antiseptic or antimicrobial impregnated catheters | 0 |
AA-2 | Antimicrobial lock therapy for long-term catheters | 0 |
AA-3 | Weekly rt-PA after hemodialysis | 0 |
AA-4 | Infusion or vascular access teams | 0 |
AA-5 | Antimicrobial ointment at hemodialysis exit sites | 0 |
AA-6 | Antiseptic hub caps and port protectors | 0 |
EP-After-1 | ICU nurse staffing and float nurses | 0 |
EP-After-2 | Chlorhexidine dressings over 2 months | 0 |
EP-After-3 | Dressing change intervals for nontunneled catheters | 0 |
EP-After-4 | Hub and connector disinfection before access | 0 |
EP-After-5 | Daily review and removal of unneeded catheters | 0 |
EP-After-6 | Administration set replacement up to 7 days | 0 |
EP-After-7 | CLABSI surveillance and rate reporting | 0 |
EP-At-1 | Insertion checklist and aseptic observation | 0 |
EP-At-2 | Hand hygiene before insertion and manipulation | 0 |
EP-At-3 | Subclavian site preference and PICC limits | 0 |
EP-At-4 | All-inclusive catheter cart or kit | 0 |
EP-At-5 | Ultrasound guidance for catheter insertion | 0 |
EP-At-6 | Maximum sterile barrier precautions at insertion | 0 |
EP-At-7 | Alcoholic chlorhexidine skin preparation | 0 |
EP-Before-1 | Accessible list of CVC indications | 0 |
EP-Before-2 | Education and competency for CVC staff | 0 |
EP-Before-3 | Daily chlorhexidine bathing in ICU | 0 |
IMP-1 | Technical and socioadaptive implementation base | 0 |
IMP-2 | Engaging frontline and senior champions | 0 |
IMP-3 | Training on indications, barriers and daily necessity | 0 |
IMP-4 | Standardized competency checklist and patient education | 0 |
IMP-5 | Evaluating with goals, feedback and trend review | 0 |
INTRO-01 | Additional approaches need a risk assessment | 0 |
INTRO-02 | Purpose and limits of the guidance | 0 |
INTRO-03 | Panel, literature search and grading process | 0 |
INTRO-04 | Rationale, burden and risk factors | 0 |
INTRO-05 | Surveillance methods and definitions | 0 |
INTRO-06 | Prior guidance and infrastructure requirements | 0 |
NR-1 | No antimicrobial prophylaxis for catheter insertion | 0 |
NR-2 | No routine replacement of catheters | 0 |
PM-External-1 | State-mandated CLABSI reporting | 0 |
PM-External-2 | Reporting to external quality initiatives | 0 |
PM-Outcome-1 | CLABSI rate per 1,000 catheter days | 0 |
PM-Outcome-2 | Risk-adjusted CLABSI comparison with dSIR and pSIR | 0 |
PM-Process-1 | Central line insertion checklist compliance | 0 |
PM-Process-2 | Daily documentation of continued CVC need | 0 |
PM-Process-3 | Aseptic infusion simulation competency measure | 0 |
PM-Process-4 | Device utilization and SUR tracking | 0 |
UI-1 | Needleless connectors as prevention measure | 0 |
UI-2 | Surveillance of other catheter types | 0 |
UI-3 | Transparent dressings and CLABSI risk | 0 |
UI-4 | Chlorhexidine use and bacterial resistance | 0 |
UI-5 | Sutureless securement devices | 0 |
UI-6 | Silver zeolite umbilical catheters in preterm infants | 0 |
UI-7 | Caps versus manual hub disinfection | 0 |